The Real Risk: How Celiac Disease May Trigger Lymphoma in Some Patients
This finding may aid in early detection
According to Dr. Lara Bennett of Worldwide Cancer Research, these findings might also affect early detection. Doctors would now know who exactly to screen for this type of cancer, or what specifically to look for in RCD II patients who have developed severe health issues. Dr. Jeroen van Bergen, also of Worldwide Cancer Research, mentions that the next possible phase to this research would be to identify when exactly the three main cytokines play a larger role in the onset of EATL. He claims that it’s quite possible that a RCD II patient has been enduring intestinal inflammation for decades at the time of the lymphoma diagnosis.
